TSE:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis C$6.21 +0.01 (+0.16%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Aurora Cannabis Stock (TSE:ACB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aurora Cannabis alerts:Sign Up Key Stats Today's RangeC$6.18▼C$6.2850-Day RangeC$5.37▼C$8.3352-Week RangeC$4.95▼C$9.90Volume203,467 shsAverage Volume535,487 shsMarket CapitalizationC$339.74 millionP/E RatioN/ADividend YieldN/APrice TargetC$8.75Consensus RatingStrong Buy Company Overview Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries. Read More Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingStrong Buy Amount of Analyst CoverageAurora Cannabis has received no research coverage in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -7.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -7.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ACB. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ACB. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Aurora Cannabis this week, compared to 1 article on an average week.Search Interest16 people have searched for ACB on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$46,640.00 in company stock and sold C$0.00 in company stock.Percentage Held by InstitutionsOnly 13.38% of the stock of Aurora Cannabis is held by institutions.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address ACB Stock News HeadlinesInsider Buying: Aurora Cannabis Inc. (TSE:ACB) Senior Officer Buys 8,000 Shares of StockJune 25, 2025 | insidertrades.comAurora Cannabis Inc. (ACB) Income Statement - Yahoo FinanceJuly 3 at 6:34 PM | finance.yahoo.comBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.July 4 at 2:00 AM | Golden Portfolio (Ad)Aurora spikes on expanded pricing program for medical cannabisJune 26, 2025 | msn.comAurora Cannabis Inc.: Aurora Cannabis Denies News of Acquisition of MedLeaf TherapeuticsJune 19, 2025 | finanznachrichten.deFed meeting, housing data, initial jobless claims: What to WatchJune 17, 2025 | finance.yahoo.comWhat To Expect From Aurora Cannabis Inc (TSX:ACB) Q4 2025 EarningsJune 17, 2025 | finance.yahoo.comAurora Cannabis introduces its first inhalable resin cartridges in the U.K.April 16, 2025 | markets.businessinsider.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at C$6.11 at the start of the year. Since then, ACB stock has increased by 1.6% and is now trading at C$6.21. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (TSE:ACB) posted its quarterly earnings results on Wednesday, November, 6th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of ($0.30) by $0.35. Aurora Cannabis had a negative trailing twelve-month return on equity of 8.36% and a negative net margin of 22.55%. How do I buy shares of Aurora Cannabis? Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Meta Platforms (META), NVIDIA (NVDA), Organigram (OGI) and Aurora Cannabis (ACBFF). Company Calendar Last Earnings11/06/2024Today7/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:ACB CIKN/A Webauroramj.com Phone+1-604-3625207FaxN/AEmployees1,073Year FoundedN/APrice Target and Rating Average Stock Price TargetC$8.75 High Stock Price TargetC$9.00 Low Stock Price TargetC$8.50 Potential Upside/Downside+41.1%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)C($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$44.16 million Net Margins-22.55% Pretax MarginN/A Return on Equity-8.36% Return on Assets-1.87% Debt Debt-to-Equity Ratio18.72 Current Ratio3.42 Quick Ratio2.48 Sales & Book Value Annual SalesC$195.83 million Price / Sales1.73 Cash FlowC$4.98 per share Price / Cash Flow1.25 Book ValueC$11.03 per share Price / Book0.56Miscellaneous Outstanding Shares54,708,189Free FloatN/AMarket CapC$339.19 million OptionableNot Optionable Beta2.71 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (TSE:ACB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.